JP2012530123A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530123A5
JP2012530123A5 JP2012515567A JP2012515567A JP2012530123A5 JP 2012530123 A5 JP2012530123 A5 JP 2012530123A5 JP 2012515567 A JP2012515567 A JP 2012515567A JP 2012515567 A JP2012515567 A JP 2012515567A JP 2012530123 A5 JP2012530123 A5 JP 2012530123A5
Authority
JP
Japan
Prior art keywords
buffer solution
stress protein
target
buffer
target stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012515567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530123A (ja
JP5778666B2 (ja
Filing date
Publication date
Priority claimed from GBGB0910591.7A external-priority patent/GB0910591D0/en
Application filed filed Critical
Publication of JP2012530123A publication Critical patent/JP2012530123A/ja
Publication of JP2012530123A5 publication Critical patent/JP2012530123A5/ja
Application granted granted Critical
Publication of JP5778666B2 publication Critical patent/JP5778666B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012515567A 2009-06-19 2010-06-21 タンパク質複合体の精製方法 Expired - Fee Related JP5778666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0910591.7 2009-06-19
GBGB0910591.7A GB0910591D0 (en) 2009-06-19 2009-06-19 Method for the purification of protein complexes
PCT/GB2010/051023 WO2010146401A1 (en) 2009-06-19 2010-06-21 Method for the purification of protein complexes

Publications (3)

Publication Number Publication Date
JP2012530123A JP2012530123A (ja) 2012-11-29
JP2012530123A5 true JP2012530123A5 (https=) 2013-08-08
JP5778666B2 JP5778666B2 (ja) 2015-09-16

Family

ID=40941082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515567A Expired - Fee Related JP5778666B2 (ja) 2009-06-19 2010-06-21 タンパク質複合体の精製方法

Country Status (9)

Country Link
US (1) US10040820B2 (https=)
EP (1) EP2442825B1 (https=)
JP (1) JP5778666B2 (https=)
CN (1) CN102458460B (https=)
AU (1) AU2010261505B2 (https=)
GB (1) GB0910591D0 (https=)
IN (1) IN2012DN00250A (https=)
WO (1) WO2010146401A1 (https=)
ZA (1) ZA201200420B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012051147A1 (en) * 2010-10-11 2012-04-19 Abbott Laboratories Processes for purification of proteins
GB201104897D0 (en) * 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
WO2013011095A1 (en) * 2011-07-21 2013-01-24 Biotech Tools S.A. Dosage of dnak
WO2018226907A2 (en) * 2017-06-07 2018-12-13 University Of Maryland, Baltimore Country Factory-on-a-chip for production of biologically derived medicines/biopharmaceuticals/biologics/ biotherapeutics
KR102270048B1 (ko) * 2020-07-10 2021-06-28 주식회사 녹십자 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
WO1997010000A1 (en) * 1995-09-13 1997-03-20 Fordham University Therapeutic and prophylactic methods using heat shock proteins
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
GB9818133D0 (en) 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine
AUPQ233799A0 (en) 1999-08-19 1999-09-09 Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales Recombinant sub-unit vaccine
GB9919733D0 (en) 1999-08-19 1999-10-20 Colaco Camilo Vaccines against intracellular pathogens
GB9919734D0 (en) 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
GB0021757D0 (en) 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
WO2002028407A1 (en) * 2000-09-29 2002-04-11 University Of Connecticut Health Center Methods of recovering heat shock proteins and complexes thereof
US20020172682A1 (en) * 2000-10-20 2002-11-21 University Of Connecticut Health Center Using heat shock proteins to increase immune response
US7132109B1 (en) * 2000-10-20 2006-11-07 University Of Connecticut Health Center Using heat shock proteins to increase immune response
US6875849B2 (en) 2001-05-01 2005-04-05 Arizona Board Of Regents Of Behalf Of The University Of Arizona Methods of recovering chaperone proteins and complexes thereof
WO2003092624A2 (en) 2002-05-02 2003-11-13 University Of Connecticut Health Center Use of heat shock proteins to enhance efficacy of antibody therapeutics
DE60335549D1 (de) * 2003-11-12 2011-02-10 Alfa Biogene Internat B V Gewinnung von Hitzeschockproteinen
GB0816242D0 (en) * 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes

Similar Documents

Publication Publication Date Title
JP2012530123A5 (https=)
MX2021004898A (es) Enzima de crispr/cas12f y sistema novedosos.
MX2021000210A (es) Metodos y productos para transfeccion de celulas.
FI3393510T3 (fi) Zika-virusrokote
EP4180526A3 (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
JP2012530782A5 (https=)
RU2012146084A (ru) Способ очистки витамин-к-зависимых белков, таких как коагуляционный фактор ix
US20190382461A1 (en) Fusion polypeptides and methods of use
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
WO2023240137A8 (en) Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
BR112014003841A2 (pt) estratégia de múltiplas cópias para produção em alto título e alta pureza de proteínas de múltiplas subunidades tal como anticorpos em micróbios transformados tal como pichia pastoris
EP2748180A1 (en) Protein purification by anion exchange chromatography
EA201000860A1 (ru) С-с-алкилимидазолбисфосфонаты
JP2013524775A5 (https=)
JP2014518508A5 (https=)
JP2007521027A (ja) ウシ胎仔血清を含まない培地組成
JPWO2023154822A5 (https=)
JP2014510093A5 (https=)
JPWO2015050191A1 (ja) 二重鎖リボ核酸の精製方法
CA2381708C (en) Immunogenic protein against piscirickettsia salmonis
Subedi et al. Isolation of proteins from extracellular vesicles (EVs) for mass spectrometry-based proteomic analyses
JP6441906B2 (ja) ヒト凝固因子軽鎖タンパク質及びその使用
US20260034159A1 (en) Methods for producing cyclic dinucleotides